| 000 | 01831 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517201114.0 | ||
| 264 | 0 | _c20181112 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1090-0535 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYan, Zhenzhen | |
| 245 | 0 | 0 |
_aInhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation. _h[electronic resource] |
| 260 |
_bMolecular vision _c2018 |
||
| 300 |
_a83-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Cycle Proteins |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aChoroid _xmetabolism |
| 650 | 0 | 4 |
_aChoroidal Neovascularization _xetiology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEndothelial Cells _xmetabolism |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aLight Coagulation _xadverse effects |
| 650 | 0 | 4 |
_aMacular Degeneration _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aPhosphoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPlatelet Endothelial Cell Adhesion Molecule-1 _xgenetics |
| 650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aRanibizumab _xpharmacology |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xgenetics |
| 650 | 0 | 4 | _aYAP-Signaling Proteins |
| 700 | 1 | _aShi, Haihong | |
| 700 | 1 | _aZhu, Rongrong | |
| 700 | 1 | _aLi, Lele | |
| 700 | 1 | _aQin, Bai | |
| 700 | 1 | _aKang, Lihua | |
| 700 | 1 | _aChen, Hui | |
| 700 | 1 | _aGuan, Huaijin | |
| 773 | 0 |
_tMolecular vision _gvol. 24 _gp. 83-93 |
|
| 999 |
_c28065628 _d28065628 |
||